Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California Ephedrine Alkaloid Supplement Labeling Bill Veto Unexpected

This article was originally published in The Tan Sheet

Executive Summary

California legislation requiring more stringent labeling for ephedrine-alkaloid dietary supplements was vetoed Sept. 30 by Gov. Gray Davis (D). The move came as a surprise to industry and to the office of Assemblywoman Susan Davis (D), who sponsored the bill.

You may also be interested in...



Calif. Ephedra Laws To Be Implemented With Help From NNFA

The National Nutritional Foods Association is working with the California Department of Health to help create standardized education programs for retail employees to enforce the state's new ephedra laws

Calif. Ephedra Laws To Be Implemented With Help From NNFA

The National Nutritional Foods Association is working with the California Department of Health to help create standardized education programs for retail employees to enforce the state's new ephedra laws

Calif. Ephedra Laws To Be Implemented With Help From NNFA

The National Nutritional Foods Association is working with the California Department of Health to help create standardized education programs for retail employees to enforce the state's new ephedra laws

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel